Synthetic Phosphonopyrazole Mimetics and Antibodies for Detection and Analysis of Protein Histidine Phosphorylation

Background

Protein phosphorylation is a fundamental post-translational modification that regulates a wide array of cellular processes, including signal transduction, metabolism, and gene expression. While phosphorylation of serine, threonine, and tyrosine residues has been extensively studied and is well understood, histidine phosphorylation remains comparatively enigmatic. This is despite its recognized roles in both prokaryotic and eukaryotic signaling pathways, such as those involved in chromatin biology and G-protein signaling. The need to study histidine phosphorylation is underscored by its implication in disease states, including certain cancers, where aberrant phosphorylation events can drive pathological changes. However, the field has been hampered by a lack of robust tools for detecting and characterizing this modification, limiting our understanding of its biological significance.

The main challenge in studying histidine phosphorylation arises from the inherent chemical instability of phosphohistidine, particularly under acidic conditions commonly used in protein analysis. The phosphoramidate bond in phosphohistidine is highly labile, leading to rapid hydrolysis and loss of the modification during sample preparation and analysis. This instability has prevented the generation of reliable immunogens and, consequently, the development of specific antibodies capable of recognizing phosphohistidine. As a result, current approaches are unable to selectively detect, quantify, or enrich phosphohistidine-containing proteins, in stark contrast to the well-established tools available for other phosphorylated amino acids. This technical gap has significantly impeded progress in elucidating the roles of histidine phosphorylation in health and disease.

Technology

This technology enables the detection and study of protein histidine phosphorylation by employing synthetic phosphonopyrazole analogs as stable mimetics of phosphohistidine. These analogs are designed with a phosphonopyrazole scaffold that resists hydrolysis, overcoming the inherent instability of natural phosphohistidine, which rapidly degrades under physiological and laboratory conditions. The mimetics can be conjugated to carrier proteins to form immunogens, which are then used to generate highly specific antibodies that recognize phosphohistidine residues in proteins. These antibodies do not cross-react with non-phosphorylated histidine or other phosphorylated amino acids, allowing for precise detection, quantification, and enrichment of phosphohistidine-modified proteins in biological samples. The technology supports a range of applications, including immunoassays, diagnostic kits, and research tools for investigating cellular signaling pathways and disease mechanisms involving histidine phosphorylation.

The differentiation of this technology lies in its ability to address a longstanding technical barrier in the field of protein phosphorylation research. Unlike traditional approaches, which have been hampered by the chemical lability of phosphohistidine, the use of phosphonopyrazole-based mimetics provides a chemically stable surrogate that faithfully mimics the structure and electrostatic properties of natural phosphohistidine. This stability enables the reliable generation of specific antibodies and the development of robust immunoassays, analogous to those available for serine, threonine, and tyrosine phosphorylation. The technology’s versatility is further enhanced by its compatibility with various conjugation chemistries, detection formats, and antibody production methods, including phage display. By making histidine phosphorylation accessible to routine biochemical and diagnostic analysis, this solution opens new avenues for basic research and clinical applications, particularly in areas where aberrant histidine phosphorylation is implicated in disease.

Benefits

• Provides chemically stable synthetic mimetics of phosphohistidine that resist hydrolysis, enabling reliable study of histidine phosphorylation.
• Enables generation of highly specific antibodies that selectively recognize phosphohistidine without cross-reacting with non-phosphorylated histidine or other phosphorylated amino acids.
• Facilitates sensitive detection, quantification, and enrichment of phosphohistidine-modified proteins in biological samples through immunoassays and diagnostic kits.
• Supports research into the biological roles and signaling pathways involving histidine phosphorylation in both prokaryotic and eukaryotic systems.
• Provides tools for disease diagnosis and biomarker discovery related to aberrant histidine phosphorylation, such as certain cancers.
• Offers potential for inhibitor development targeting protein phosphohistidine phosphatases, aiding biochemical studies and drug discovery.
• Includes versatile conjugation chemistries and assay formats (e.g., ELISA, phage display) for broad applicability in research and clinical diagnostics.

Applications

• Phosphohistidine protein detection kits
• Antibody-based diagnostic assays
• Enrichment of pHis-modified proteins
• Cell signaling pathway research
• Drug discovery for kinase inhibitors

Additional info

These synthetic phosphonopyrazole analogs provide chemically stable mimetics of phosphohistidine, overcoming the lability of natural histidine phosphorylation. By employing a hydrolysis-resistant scaffold, these compounds function as haptens for carrier protein conjugation. The resulting immunogens facilitate the production of highly specific antibodies for detecting and quantifying histidine-phosphorylated proteins in biological samples, avoiding cross-reactivity with other phosphorylated residues or non-phosphorylated histidine.